Vetinnova
PORTAL DE REFERENCIA SOBRE I+D+i
EN SANIDAD ANIMAL
 

Área Personal

Acceso al área privada de la web
Búsqueda de texto en la web

fbus

CREA TU PERFIL Grupo de Investigación
Grupo de Investigación
CREA TU PERFIL Empresa
Empresa

 Safe and effective vaccine against Clostridium perfringens in poultry

The vaccine consists of a combination of recombinant NetB and alpha-toxin, both detoxified. C. perfringens infections in poultry may present as an acute clinical disease, with high mortality at 2 to 5 weeks of age, or in a subclinical form leading to reduced weight gain which costs the worldwide poultry industry 2 billion USD annually (or 0,05USD per bird) Proof of concept in target species (Ross308 broilers) Immunisation with NetB- and alpha-toxoid reduced lesion scores completely. None of the animals vaccinated with a combination of NetB and CPA developed necrotic enteritis lesions after challenge.
· Socio buscado Partnering We are looking for partners that are interested to market the vaccine and we are open to assist during the transfer of the technology and during the development phase.

A recombinant vaccine based on toxoids of NetB and alfatox fit for vaccination of chickens against Clostridium perfringens.

Sven Arnouts
sven.arnouts@ugent.be
+32 495 707 334

Una iniciativa de

Vet + i
Vetdivulga
Ayuda PTR2020- 001197 financiada por:

UNION EUROPEA - FONDO EUROPEO DE DESARROLLO REGIONAL